Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries
Diarrheal disease caused by rotavirus claims approximately 500 000 lives each year, mostly in low-income countries. Many of these deaths are preventable through the use of available rotavirus vaccines. Yet, in spite of a WHO recommendation that these vaccines be adopted into all national immunizatio...
Saved in:
Main Authors: | Anant Bhan (Author), Shane K. Green (Author) |
---|---|
Format: | Book |
Published: |
Edinburgh University Global Health Society,
2011-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines
by: Benjamin Lee
Published: (2021) -
Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules
by: Andrew Clark, PhD, et al.
Published: (2019) -
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
by: Prashant Kumar, et al.
Published: (2021) -
The economics of vaccination in low- and middle-income countries
by: J.A. Fox-Rushby, et al.
Published: (2004) -
Rotavirus genotypes in children under five years hospitalized with diarrhea in low and middle-income countries: Results from the WHO-coordinated Global Rotavirus Surveillance Network.
by: Sebastien Antoni, et al.
Published: (2023)